This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diep, B. A.
Right arrow Articles by Perdreau-Remington, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diep, B. A.
Right arrow Articles by Perdreau-Remington, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2004, p. 2080-2084, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2080-2084.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Widespread Skin and Soft-Tissue Infections Due to Two Methicillin-Resistant Staphylococcus aureus Strains Harboring the Genes for Panton-Valentine Leucocidin

Binh An Diep,1,2 George F. Sensabaugh,1 Naraporn S. Somboona,1 Heather A. Carleton,2 and Françoise Perdreau-Remington2*

Division of Infectious Diseases, School of Public Health, University of California, Berkeley, California 94720,1 Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California 941102

Received 28 November 2003/ Returned for modification 27 January 2004/ Accepted 11 February 2004


arrow
ABSTRACT
 
Infections caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) are emerging as a major public health problem. CA-MRSA has been associated previously with skin and soft-tissue infection (SSTI) and with carriage of staphylococcal cassette chromosome mec (SCCmec) type IV and the Panton-Valentine leucocidin (PVL) virulence factor. To assess the clonal distribution of PVL-carrying strains and the association with SSTI in the San Francisco Bay area, we surveyed six collections of S. aureus isolates—671 isolates in all—collected between 1997 and 2002 originating from inpatient and outpatient clinical specimens and from a community-based sampling. Isolates were genotyped by pulsed-field gel electrophoresis, multilocus restriction fragment typing, and multilocus sequence typing and assayed for the PVL virulence factor. The S. aureus populations showed a high proportion of PVL-carrying strains, with frequencies ranging up to 70% in MRSA isolated from jail inmate patients and 69% in MRSA from patients receiving surgical treatment at an outpatient clinic specializing in treating SSTIs. PVL-carrying isolates were identified in nine clonal groups, but 88.5% of the PVL-carrying MRSA isolates belonged to only two clonal groups. These two clonal groups carried the SCCmec type IV resistance determinant and were more likely than other clonal groups to be recovered from SSTI sites than from other sites (P < 0.0001). There is evidence of clonal replacement over the period from 1999 to 2002, with one of these two clonal groups being supplanted by the other.


arrow
INTRODUCTION
 
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infection worldwide. Hospital-associated MRSA strains are typically resistant to multiple antibiotics, compounding the challenge of finding effective treatment options. It is commonly accepted that MRSA strains can flourish in the hospital environment due to the selection pressure of antibiotic use but have low prevalence outside the health care setting due to the "fitness cost" of resistance (21). Recently, however, there have been reports indicating an increased incidence of MRSA infections, mostly skin and soft-tissue infections (SSTIs), afflicting individuals with no apparent risk factors for hospital acquisition (6, 13, 17, 33). These reports have raised questions regarding the origin of these presumed community-acquired MRSA (CA-MRSA) strains and the possibility of their increasing prevalence in hospital and community populations.

The newly described CA-MRSA strains possess several features that distinguish them from nosocomial MRSA. First, most are non-multidrug resistant, in contrast to the multidrug-resistant MRSA strains typically found in the hospital setting (1, 17). Second, methicillin resistance is conferred by carriage of the mecA gene on the recently identified type IV staphylococcal chromosomal cassette mec (SCCmec) element (7, 22). Third, they carry the genes for Panton-Valentine leucocidin (PVL), a bicomponent cytotoxin virulence factor associated with SSTIs as well as with more serious infections, e.g., severe necrotizing pneumonia (10, 15, 37). PVL is encoded by two cotranscribed genes, lukS-PV and lukF-PV, present in a prophage segment integrated in the S. aureus chromosome (32). Heretofore, the PVL genes have been detected infrequently (<5%) in hospital and community S. aureus isolates (20, 31). Last, this combination of features appears on geographically dispersed S. aureus strains with unrelated genetic backgrounds, indicative of multiple independent clonal origins (37). Taken together, these observations suggest the emergence of new strains of S. aureus bearing the type IV SCCmec element and PVL that are particularly well adapted for survival in the community setting (10, 37).

To gain a better understanding of the prevalence, clonal distribution, and population dynamics of PVL+ MRSA, we surveyed isolates collected over a period of 6 years from hospital and community populations in the San Francisco area. Our findings indicate that even at a local level, PVL is circulating in multiple clonal lineages, mostly associated with MRSA bearing the SCCmec type IV element but in some cases in methicillin-sensitive S. aureus (MSSA) strains. Two clonal groups, both significantly associated with SSTIs, dominate the survey.

(This work was presented in part at the 103rd General Meeting of the American Society for Microbiology, May 2003, Washington, D.C.)


arrow
MATERIALS AND METHODS
 
Bacterial isolates. Six distinct collections of S. aureus isolates were surveyed in this study. These collections originated from the Molecular Epidemiology Research Laboratory (MERL), which provides molecular epidemiologic services to the San Francisco Community Health Network. The network includes San Francisco General Hospital (SFGH, a university-affiliated acute-care public hospital with a regional trauma center), 13 citywide outpatient clinics, a publicly funded long-term care facility, a chronic mental health care facility, a home health care network, and a patient clinic for the San Francisco County jails. MERL has archived over 90% of MRSA isolates cultured from inpatient and outpatient clinical S. aureus specimens submitted to the Clinical Microbiology Laboratory at SFGH since 1996; MSSA are typically not archived. Of the MRSA, about 20% are from blood or other sterile sites, 20% are of respiratory origins, 10% are from urinary tract infections, and 50% are from wounds and cutaneous abscesses.

Five collections originated from inpatient and outpatient populations with S. aureus infections (Table 1). The first, SFGH/MRSA-1, originated from inpatient and outpatient sources at SFGH and consisted of 101 MRSA isolates recovered from unique patient clinical specimens (abscess or wound, n = 47; blood, bone, and tissue, n = 22; respiratory, n = 17; urine, n = 12; and catheter, n = 3) between August 1999 and March 2000; the 101 isolates were randomly selected from 182 MRSA isolates archived in the MERL strain bank during this period. A comparison collection consisted of 89 consecutive MSSA clinical isolates recovered from hospitalized patients identified during November and December 1999, the middle of the sampling period of the first MRSA collection. To assess temporal changes in the distribution of MRSA clonal groups among hospitalized patients at SFGH, a sample set (SFGH/MRSA-2) consisting of 82 MRSA isolates was selected at random from 563 unique patient isolates collected during 2002. The fourth collection consisted of MRSA isolates collected from outpatients receiving surgical treatment at the Integrated Soft-tissue Infection Services (ISIS) Clinic between July and December 2000 (16; E. D. Charlebois, D. R. Bangsberg, N. Moss, and F. Perdreau-Remington, Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother. p. 120, abstr. C2-306, 2001). Isolates originated from the first 64 consecutive unique patients who presented with culture-positive abscesses and wounds. The fifth collection consisted of clinical MRSA isolates from 151 unique incarcerated patients from five San Francisco County jails collected between January 1997 and December 2002; of these, 85% were recovered from abscesses or wounds (30). Overall, these five collections contained isolates from 487 unique patients.


View this table:
[in this window]
[in a new window]
  		TABLE 1. PVL+ S. aureus in six sample populations

To contrast community carriage against the clinical isolates, we surveyed 184 S. aureus isolates from nasal swabs collected as part of a population-based community prevalence study among the urban poor in San Francisco (5). These samples were collected between August 1999 and April 2000; of these, 23 were MRSA and the remainder were MSSA.

Bacterial characterization. S. aureus isolates were tested for phenotypic resistance to oxacillin by the salt agar method (35). Susceptibility to ciprofloxacin, tetracycline, gentamicin, erythromycin, cotrimoxazole, rifampin, clindamycin, and vancomycin was tested using broth microdilution with the MicroScan WalkAway 96 instrument (Dade Behring), and results were interpreted in accordance with the National Committee for Clinical Laboratory Standards guidelines (3). The structural features unique to each of the four major allotypes of the SCCmec element, types I through IV (18, 22), were determined by a previously described PCR-based multiplex assay (29).

All isolates were genotyped by PFGE with SmaI as previously described (5); the guidelines of Tenover et al. were used to interpret the PFGE patterns for genetic relatedness (36). Multilocus restriction fragment typing (MLRFT) was performed to provide an assessment of restriction site variation in seven housekeeping gene loci dispersed around the genome (11). Unique allelic combinations of the seven housekeeping genes defines a San Francisco (SF) type number (e.g., SF13). The combination of MLRFT and PFGE pattern type defines a clonal group (e.g., SF13:Z). Multilocus sequence typing (MLST) was performed on representative isolates from each clonal group (11); sequence types (ST) were assigned with reference to the MLST database (http://www.mlst.net). Some samples were additionally typed at the spa locus (34). PVL genes were detected by coamplification of lukS-PV and lukF-PV genes as described by Lina et al. (20). A subset of the PVL PCR amplicons were sequenced to confirm the specificity of the lukS-PV and lukF-PV primers.

Statistical analysis. Associations between categorical variables were tested by Fisher's exact test using the statistical program STATA (Stata Corp LP, College Station, Tex.) (2).


arrow
RESULTS
 
High prevalence of PVL in SSTI-associated MRSA isolates. Six S. aureus collections consisting of 671 isolates were tested for the prevalence of PVL. Overall, 33.5% (225 of 671) of the isolates were positive for PVL, although frequencies differed widely between collections (Table 1). Among two clinical SFGH MRSA collections from inpatient and outpatient sources, 37% (37 of 101) of isolates recovered in 1999-2000 and 35.4% (29 of 82) obtained in 2002 were positive for PVL. PVL prevalence among two clinical outpatient collections, originating from San Francisco jail inmate patients in the period from 1997 to 2002 and ISIS Clinic patients in 2000, was 70.2% (106 of 151) and 68.8% (44 of 64), respectively. In contrast to the four MRSA collections, the two collections containing predominantly MSSA isolates had significantly lower PVL prevalence: 6.7% (6 of 89) among consecutive clinical MSSA isolates from SFGH in 1999 and 1.6% (3 of 184) among a mixed set of MSSA (n = 161) and MRSA (n = 23) isolates from the nares of San Francisco urban poor in 1999-2000. PVL was found to be associated with SSTIs in the three MRSA collections with samples isolated from diverse sites of infection, i.e., the two clinical SFGH/MRSA collections and the clinical jail inmate collection, as well as in the collection from the ISIS Clinic population, which consisted almost entirely of patients with SSTIs (P < 0.0001) (Table 1).

The PVL+ isolates were distributed among nine clonal groups as defined by MLRFT, MLST, and PFGE and included 9 MSSA and 216 MRSA isolates (Table 2). All the MRSA isolates carried the type IV SCCmec element. As shown in Table 2, most of the 225 PVL+ isolates fell into two clonal groups: 57% in SF13:Z and 30% in SF16:S. The former belonged to ST-30 complex, and the latter belonged to the ST-8 complex, both successful pandemic MRSA complexes (12, 26, 28, 37). Most isolates identified as belonging to these two clonal groups were PVL+: 83% of the SF13:Z isolates and 100% of the SF16:S isolates. Within SF13:Z, 129 of the 155 isolates were MRSA, and of these, 128 (99%) were PVL+. SF16:S has been classified as a distinct clonal group based on its PFGE pattern; although the SF16:S and the SF16:C clonal groups have the same sequence type (ST8) and spa type (YHGFMBQBLO), they share only 9 of 15 PFGE bands (Fig. 1). In contrast to the 100% PVL+ presence in SF16:S, PVL genes were detected in only 9 of 111 SF16:C isolates, and of these, 5 were MSSA. Of the remaining six PVL+ clonal types, only SF1:K and SF25:P, corresponding to ST1 and ST59 (Table 2), have been associated previously with PVL (37).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Differentiation of PVL+ S. aureus isolates into clonal groups according to isolate population



View larger version (64K):
[in this window]
[in a new window]
  		FIG. 1. PFGE of SmaI-digested DNA from representative PVL+ strains from different clonal groups. Lane 1, SF13:Z (ST30); lanes 2 and 4, SF16:S (ST8); lane 3, SF16:C (ST8); and lane 5, SF25:P (ST59).

Most of the PVL+ isolates were susceptible to all non-beta-lactam antibiotics. The exceptions were all in the SF16:S clonal group: 70% of isolates were resistant to ciprofloxacin, 94% were resistant to erythromycin, 27% were resistant to tetracycline, and 24% were resistant to all three.

Evidence of clonal replacement between 2000 and 2002. The San Francisco jail inmate MRSA isolates were collected over a 6-year period, 1997 to 2002, thereby allowing temporal trends in clonal distributions to be assessed (32). As noted in Table 1, 106 (70.2%) of the 151 MRSA isolates in this population were PVL positive; 97 of the 106 belonged to the SF13:Z and SF16:S clonal groups. PVL+ SF13:Z isolates first appeared in 1997, increased to 50% of isolates through the years 1998 to 2000, and then declined to 32% in 2001 and 14% in 2002. The SF16:S clonal group did not appear in the jail population until April 2001, but then it increased dramatically, ultimately accounting for 11 (31%) of the 36 MRSA isolates recovered that year and 29 (67%) of 43 MRSA isolates collected in 2002.

The same shift in clonal distribution was observed in comparing the clinical MRSA isolates from SFGH collected during 1999-2000 with those collected in 2002. The PVL+ SF16:S clonal group was not detected in the 1999-2000 isolate population but accounted for 26 of 82 (32%) of the isolates sampled in 2002 (Tables 1 and 2). Concurrently, the occurrence of PVL+ SF13:Z isolates declined from 34 of 101 (34%) in 1999-2000 to 2 of 82 (2.4%) in 2002. The SF16:S clonal group first appeared in an inpatient isolate in June 2001 (F. Perdreau-Remington, unpublished data), and the data presented here clearly show that the SF16:S clonal group is emergent in the hospital setting.


arrow
DISCUSSION
 
There has been recent speculation that PVL in combination with the type IV SCCmec element contributes to the spread of MRSA in the community, particularly in the context of SSTI (10). The findings reported here are consistent with this idea. Over one-third of the hospital MRSA isolates and over two-thirds of the outpatient MRSA isolates were found to carry the lukS-PV-lukF-PV gene complex; in contrast, less than 7% of the MSSA isolates were PVL+. Most of the PVL+ isolates (96%) were MRSA, and all the PVL+ MRSA isolates carried the type IV SCCmec element. The majority of the PVL+ MRSA strains were associated with SSTIs.

Two clonal groups, SF13:Z and SF16:S, dominated the survey, accounting for 49% of the isolates in the four MRSA collections and for 33% of all the isolates surveyed. That 91% of all the PVL+ MRSA isolates were SF13:Z or SF16:S is consistent with the idea that PVL (or some other shared factor) contributes to the success of these two clonal groups. Of additional note, the SF16:S clonal group, a group that is 100% PVL+ type IV SCCmec MRSA, has in the course of 2 years effectively supplanted the SF13:Z clonal group as the predominant strain among clinical samples from both inpatients and outpatients at SFGH.

The SF13:Z clonal group belongs to the ST30 clonal lineage. ST30 strains harboring the SCCmec type IV element have been recovered in Sweden, Germany, Spain, Argentina, and Greece (8, 12). The SF13:Z clonal group is indistinguishable in sequence type, SCCmec type, and PVL carriage from an outbreak PVL+ MRSA strain recovered from Polynesian patients seen at an Australian hospital in 1998 (26, 28). It is possible that the Oceania strain and the SF13:Z clonal group share a common origin.

The SF16:S and SF16:C clonal groups possess distinctive PFGE banding patterns (Fig. 1) despite belonging to the same MLST clonal lineage, ST8. SF16:S and SF16:C appear to correspond to the USA300 and USA500 groups described recently by McDougal et al. (23). ST8 is a well-established lineage with worldwide distribution that includes MSSA strains and MRSA strains carrying each of the four SCCmec types (12); ST8 MRSA strains carrying the SCCmec type IV element have been recovered previously in both Europe and the United States. PVL genes were detected in both SF16:S and SF16:C lineages, although at different frequencies; relatively few SF16:C isolates were PVL+, and these were split between MRSA and MSSA, whereas all the SF16:S were PVL+ MRSA. There is a recent report indicating PVL carriage by an ST8 strain (37); from the data given, it is not possible to determine whether this corresponds to an SF16:C or SF16:S strain. However, given the recent appearance of the SF16:S clonal group in this area and its rapid increase in prevalence, we speculate that SF16:S is recently derived from an SF16:C-like ancestor that underwent substantial genomic reorganization and a significant gain in fitness. Wherever the origin of the SF16:S clonal group, it is evident that this PVL+ type IV SCCmec MRSA has spread to multiple sites throughout the United States (23, 30), including the large MRSA outbreak in Los Angeles county in 2002 (4; F. Perdreau-Remington, E. Pan, H. Carleton, B. Diep, S. Harvey, and G. Sensabaugh, Abstr. 43rd Intersci. Conf. Antimicrob. Chemother., p. 382, abstr. K-1393, 2003).

The lukS-PV-lukF-PV gene complex was detected in six clonal groups in addition to SF13:Z, SF16:C, and SF16:S. Two clonal groups, SF1:K and SF25:P, were found to carry PVL at intermediate frequency (Table 2). SF1:K corresponds in sequence type to ST1, and the PVL+ strains found in this area are thus linked to the PVL+ ST1 strains responsible for CA-MRSA infections in the U.S. Midwest (14, 23), of which the fully sequenced MW2 strain is representative (3). PVL+ ST1 strains have been recently reported in the Northeastern United States, and their detection here indicates that they have achieved nationwide distribution. SF25:P belongs to the ST59 clonal lineage and is ubiquitous in the San Francisco area (9); it has been associated with both community- and hospital-acquired infections. The remaining four PVL+ isolates detected in this survey are singletons within their clonal groups; the presence of PVL in these clonal groups has not been reported previously.

The detection of PVL genes in nine different clonal groups raises the question of their origin. The lukS-PV-lukF-PV gene complex is carried on a prophage integrated in the S. aureus genome. Three PVL-bearing prophage sequences—{phi}PVL, {phi}SLT, and {phi}MW2—have been determined, and apart from the region carrying the PVL gene complex, each differs considerably in gene organization and sequence (3, 19, 25). Narita et al. (25) provide evidence of multiple additional PVL bearing prophages. It is thus likely that the PVL-bearing prophages in the clonal groups identified here have independent origins. The presence of high-prevalence PVL+ strains such as SF13:Z and SF16:S, however, raises the possibility that these strains can serve as reservoirs for the propagation of PVL to other clonal groups.

Finally, the emergence of PVL+ type IV SCCmec MRSA strains in the community raises the concern that these strains will migrate into the hospital setting (27), and indeed, this study provides evidence that this is already happening. Heretofore, CA-MRSA strains have been susceptible to antibiotics other than the ß-lactams, allowing alternative treatment options (24). However, in the hospital setting, it likely that multidrug-resistant strains will emerge, and the appearance of SF16:S isolates resistant to ciprofloxacin, erythromycin, and tetracycline may represent the first wave of multidrug-resistant CA-MRSA.


arrow
ACKNOWLEDGMENTS
 
This work was supported in part by an unrestricted grant from the Pfizer Corporation, New York, N.Y. (F.P.-R.), and by a Faculty Research Bridging Grant (G.F.S.). B.D. was supported by a Eugene Cota-Robles Fellowship.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Dept. of Medicine, University of California, San Francisco, Division of Infectious Diseases, San Francisco General Hospital, 1001 Potrero Ave., UCSF 1372, Building 100, Room 301, San Francisco, CA 94110. Phone: (415) 206-6899. Fax: (415) 206-4360. E-mail: fpr{at}epi-center.ucsf.edu. Back


arrow
REFERENCES
 
    1
  1. Adcock, P. M., P. Pastor, F. Medley, J. E. Patterson, and T. V. Murphy. 1998. Methicillin-resistant Staphylococcus aureus in two child care centers. J. Infect. Dis. 178:577-580.[Medline]
    2. 2
  2. Agresti, A. 2001. Exact inference for categorical data: recent advances and continuing controversies. Stat. Med. 20:2709-2722.[CrossRef][Medline]
    3. 3
  3. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.[CrossRef][Medline]
    4. 4
  4. Centers for Disease Control and Prevention. 2003. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002-2003. Morb. Mortal. Wkly. Rep. 52:88.[Medline]
    5. 5
  5. Charlebois, E. D., D. R. Bangsberg, N. J. Moss, M. R. Moore, A. R. Moss, H. F. Chambers, and F. Perdreau-Remington. 2002. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin. Infect. Dis. 34:425-433.[CrossRef][Medline]
    6. 6
  6. Collignon, P., I. Gosbell, A. Vickery, G. Nimmo, T. Stylianopoulos, T. Gottlieb, et al. 1998. Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Lancet 352:145-146.[CrossRef][Medline]
    7. 7
  7. Daum, R. S., T. Ito, K. Hiramatsu, F. Hussain, K. Mongkolrattanothai, M. Jamklang, and S. Boyle-Vavra. 2002. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J. Infect. Dis. 186:1344-1347.[CrossRef][Medline]
    8. 8
  8. de Sousa, M. A., C. Bartzavali, I. Spiliopoulou, I. S. Sanches, M. I. Crisostomo, and H. de Lencastre. 2003. Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J. Clin. Microbiol. 41:2027-2032.[Abstract/Free Full Text]
    9. 9
  9. Diep, B. A., F. Perdreau-Remington, and G. F. Sensabaugh. 2003. Clonal characterization of Staphylococcus aureus by multilocus restriction fragment typing, a rapid screening approach for molecular epidemiology. J. Clin. Microbiol. 41:4559-4564.[Abstract/Free Full Text]
    10. 10
  10. Dufour, P., Y. Gillet, M. Bes, G. Lina, F. Vandenesch, D. Floret, J. Etienne, and H. Richet. 2002. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin. Infect. Dis. 35:819-824.[CrossRef][Medline]
    11. 11
  11. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.[Abstract/Free Full Text]
    12. 12
  12. Enright, M. C., D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann, and B. G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99:7687-7692.[Abstract/Free Full Text]
    13. 13
  13. Fergie, J. E., and K. Purcell. 2001. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr. Infect. Dis. J. 20:860-863.[CrossRef][Medline]
    14. 14
  14. Fey, P. D., B. Said-Salim, M. E. Rupp, S. H. Hinrichs, D. J. Boxrud, C. C. Davis, B. N. Kreiswirth, and P. M. Schlievert. 2003. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:196-203.[Abstract/Free Full Text]
    15. 15
  15. Gillet, Y., B. Issartel, P. Vanhems, J. C. Fournet, G. Lina, M. Bes, F. Vandenesch, Y. Piemont, N. Brousse, D. Floret, and J. Etienne. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759.[CrossRef][Medline]
    16. 16
  16. Harris, H. W., and D. M. Young. 2002. Care of injection drug users with soft tissue infections in San Francisco, California. Arch. Surg. 137:1217-1222.[Abstract/Free Full Text]
    17. 17
  17. Herold, B. C., L. C. Immergluck, M. C. Maranan, D. S. Lauderdale, R. E. Gaskin, S. Boyle-Vavra, C. D. Leitch, and R. S. Daum. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598.[Abstract/Free Full Text]
    18. 18
  18. Ito, T., Y. Katayama, K. Asada, N. Mori, K. Tsutsumimoto, C. Tiensasitorn, and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1323-1336.[Abstract/Free Full Text]
    19. 19
  19. Kaneko, J., T. Kimura, S. Narita, T. Tomita, and Y. Kamio. 1998. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes. Gene 215:57-67.[CrossRef][Medline]
    20. 20
  20. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132.[CrossRef][Medline]
    21. 21
  21. Lipsitch, M. 2001. The rise and fall of antimicrobial resistance. Trends Microbiol. 9:438-444.[CrossRef][Medline]
    22. 22
  22. Ma, X. X., T. Ito, C. Tiensasitorn, M. Jamklang, P. Chongtrakool, S. Boyle-Vavra, R. S. Daum, and K. Hiramatsu. 2002. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 46:1147-1152.[Abstract/Free Full Text]
    23. 23
  23. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.[Abstract/Free Full Text]
    24. 24
  24. Naimi, T. S., K. H. LeDell, K. Como-Sabetti, S. M. Borchardt, D. J. Boxrud, J. Etienne, S. K. Johnson, F. Vandenesch, S. Fridkin, C. O'Boyle, R. N. Danila, and R. Lynfield. 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.[Abstract/Free Full Text]
    25. 25
  25. Narita, S., J. Kaneko, J. Chiba, Y. Piemont, S. Jarraud, J. Etienne, and Y. Kamio. 2001. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 268:195-206.[CrossRef][Medline]
    26. 26
  26. Nimmo, G. R., J. Schooneveldt, G. O'Kane, B. McCall, and A. Vickery. 2000. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J. Clin. Microbiol. 38:3926-3931.[Abstract/Free Full Text]
    27. 27
  27. O'Brien, F. G., J. W. Pearman, M. Gracey, T. V. Riley, and W. B. Grubb. 1999. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J. Clin. Microbiol. 37:2858-2862.[Abstract/Free Full Text]
    28. 28
  28. Okuma, K., K. Iwakawa, J. D. Turnidge, W. B. Grubb, J. M. Bell, F. G. O'Brien, G. W. Coombs, J. W. Pearman, F. C. Tenover, M. Kapi, C. Tiensasitorn, T. Ito, and K. Hiramatsu. 2002. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40:4289-4294.[Abstract/Free Full Text]
    29. 29
  29. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.[Abstract/Free Full Text]
    30. 30
  30. Pan, E. S., B. A. Diep, H. A. Carleton, E. D. Charlebois, G. F. Sensabaugh, B. L. Haller, and F. Perdreau-Remington. 2003. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin. Infect. Dis. 37:1384-1388.[CrossRef][Medline]
    31. 31
  31. Prevost, G., P. Couppie, P. Prevost, S. Gayet, P. Petiau, B. Cribier, H. Monteil, and Y. Piemont. 1995. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J. Med. Microbiol. 42:237-245.[Abstract/Free Full Text]
    32. 32
  32. Prevost, G., B. Cribier, P. Couppie, P. Petiau, G. Supersac, V. Finck-Barbancon, H. Monteil, and Y. Piemont. 1995. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63:4121-4129.[Abstract]
    33. 33
  33. Sattler, C. A., E. O. Mason, Jr., and S. L. Kaplan. 2002. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21:910-917.[CrossRef][Medline]
    34. 34
  34. Shopsin, B., M. Gomez, S. O. Montgomery, D. H. Smith, M. Waddington, D. E. Dodge, D. A. Bost, M. Riehman, S. Naidich, and B. N. Kreiswirth. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:3556-3563.[Abstract/Free Full Text]
    35. 35
  35. Swenson, J. M., J. A. Hindler, and L. R. Peterson. 1995. Special tests for detecting antibacterial resistance, p. 1356-1367. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
    36. 36
  36. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
    37. 37
  37. Vandenesch, F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. E. Reverdy, and J. Etienne. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978-984.[Medline]

Journal of Clinical Microbiology, May 2004, p. 2080-2084, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2080-2084.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vardakas, K. Z., Matthaiou, D. K., Falagas, M. E. (2009). Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J 34: 1148-1158 [Abstract] [Full Text]  
  • El Garch, F., Hallin, M., De Mendonca, R., Denis, O., Lefort, A., Struelens, M. J. (2009). StaphVar-DNA microarray analysis of accessory genome elements of community-acquired methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 63: 877-885 [Abstract] [Full Text]  
  • Pu, S., Han, F., Ge, B. (2009). Isolation and Characterization of Methicillin-Resistant Staphylococcus aureus Strains from Louisiana Retail Meats. Appl. Environ. Microbiol. 75: 265-267 [Abstract] [Full Text]  
  • Ma, X. X., Ito, T., Kondo, Y., Cho, M., Yoshizawa, Y., Kaneko, J., Katai, A., Higashiide, M., Li, S., Hiramatsu, K. (2008). Two Different Panton-Valentine Leukocidin Phage Lineages Predominate in Japan. J. Clin. Microbiol. 46: 3246-3258 [Abstract] [Full Text]  
  • Goering, R. V., Shawar, R. M., Scangarella, N. E., O'Hara, F. P., Amrine-Madsen, H., West, J. M., Dalessandro, M., Becker, J. A., Walsh, S. L., Miller, L. A., van Horn, S. F., Thomas, E. S., Twynholm, M. E. (2008). Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates from Global Clinical Trials. J. Clin. Microbiol. 46: 2842-2847 [Abstract] [Full Text]  
  • Fritz, S. A., Garbutt, J., Elward, A., Shannon, W., Storch, G. A. (2008). Prevalence of and Risk Factors for Community-Acquired Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Colonization in Children Seen in a Practice-Based Research Network. Pediatrics 121: 1090-1098 [Abstract] [Full Text]  
  • Takano, T., Higuchi, W., Otsuka, T., Baranovich, T., Enany, S., Saito, K., Isobe, H., Dohmae, S., Ozaki, K., Takano, M., Iwao, Y., Shibuya, M., Okubo, T., Yabe, S., Shi, D., Reva, I., Teng, L.-J., Yamamoto, T. (2008). Novel Characteristics of Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains Belonging to Multilocus Sequence Type 59 in Taiwan. Antimicrob. Agents Chemother. 52: 837-845 [Abstract] [Full Text]  
  • Kennedy, A. D., Otto, M., Braughton, K. R., Whitney, A. R., Chen, L., Mathema, B., Mediavilla, J. R., Byrne, K. A., Parkins, L. D., Tenover, F. C., Kreiswirth, B. N., Musser, J. M., DeLeo, F. R. (2008). From the Cover: Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proc. Natl. Acad. Sci. USA 105: 1327-1332 [Abstract] [Full Text]  
  • Rajendran, P. M., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P., Harris, H. (2007). Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection. Antimicrob. Agents Chemother. 51: 4044-4048 [Abstract] [Full Text]  
  • Tsang, L. H., Daily, S. T., Weiss, E. C., Smeltzer, M. S. (2007). Mutation of traP in Staphylococcus aureus Has No Impact on Expression of agr or Biofilm Formation. Infect. Immun. 75: 4528-4533 [Abstract] [Full Text]  
  • Rossney, A. S., Shore, A. C., Morgan, P. M., Fitzgibbon, M. M., O'Connell, B., Coleman, D. C. (2007). The Emergence and Importation of Diverse Genotypes of Methicillin-Resistant Staphylococcus aureus (MRSA) Harboring the Panton-Valentine Leukocidin Gene (pvl) Reveal that pvl Is a Poor Marker for Community-Acquired MRSA Strains in Ireland. J. Clin. Microbiol. 45: 2554-2563 [Abstract] [Full Text]  
  • Shastry, L., Rahimian, J., Lascher, S. (2007). Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections in Men Who Have Sex With Men in New York City. Arch Intern Med 167: 854-857 [Full Text]  
  • Yamamoto, T., Dohmae, S., Saito, K., Otsuka, T., Takano, T., Chiba, M., Fujikawa, K., Tanaka, M. (2006). Molecular Characteristics and In Vitro Susceptibility to Antimicrobial Agents, Including the Des-Fluoro(6) Quinolone DX-619, of Panton-Valentine Leucocidin-Positive Methicillin-Resistant Staphylococcus aureus Isolates from the Community and Hospitals. Antimicrob. Agents Chemother. 50: 4077-4086 [Abstract] [Full Text]  
  • Aiello, A. E., King, N. B., Foxman, B. (2006). Ethical Conflicts in Public Health Research and Practice: Antimicrobial Resistance and the Ethics of Drug Development. AJPH 96: 1910-1914 [Abstract] [Full Text]  
  • Noguchi, N., Nakaminami, H., Nishijima, S., Kurokawa, I., So, H., Sasatsu, M. (2006). Antimicrobial Agent of Susceptibilities and Antiseptic Resistance Gene Distribution among Methicillin-Resistant Staphylococcus aureus Isolates from Patients with Impetigo and Staphylococcal Scalded Skin Syndrome.. J. Clin. Microbiol. 44: 2119-2125 [Abstract] [Full Text]  
  • Layer, F., Ghebremedhin, B., Konig, W., Konig, B. (2006). Heterogeneity of Methicillin-Susceptible Staphylococcus aureus Strains at a German University Hospital Implicates the Circulating-Strain Pool as a Potential Source of Emerging Methicillin-Resistant S. aureus Clones.. J. Clin. Microbiol. 44: 2179-2185 [Abstract] [Full Text]  
  • Sabol, K. E, Echevarria, K. L, Lewis, J. S II (2006). Community-Associated Methicillin-Resistant Staphylococcus aureus: New Bug, Old Drugs. The Annals of Pharmacotherapy 40: 1125-1133 [Abstract] [Full Text]  
  • Gonzalez, B. E., Teruya, J., Mahoney, D. H. Jr, Hulten, K. G., Edwards, R., Lamberth, L. B., Hammerman, W. A., Mason, E. O. Jr, Kaplan, S. L. (2006). Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children. Pediatrics 117: 1673-1679 [Abstract] [Full Text]  
  • King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., Blumberg, H. M. (2006). Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections.. ANN INTERN MED 144: 309-317 [Abstract] [Full Text]  
  • Bocchini, C. E., Hulten, K. G., Mason, E. O. Jr, Gonzalez, B. E., Hammerman, W. A., Kaplan, S. L. (2006). Panton-Valentine Leukocidin Genes Are Associated With Enhanced Inflammatory Response and Local Disease in Acute Hematogenous Staphylococcus aureus Osteomyelitis in Children. Pediatrics 117: 433-440 [Abstract] [Full Text]  
  • Miles, G., Jayasinghe, L., Bayley, H. (2006). Assembly of the Bi-component Leukocidin Pore Examined by Truncation Mutagenesis. J. Biol. Chem. 281: 2205-2214 [Abstract] [Full Text]  
  • Stephens, A. J., Huygens, F., Inman-Bamber, J., Price, E. P., Nimmo, G. R., Schooneveldt, J., Munckhof, W., Giffard, P. M. (2006). Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol 55: 43-51 [Abstract] [Full Text]  
  • van Duijkeren, E., Wolfhagen, M. J. H. M., Heck, M. E. O. C., Wannet, W. J. B. (2005). Transmission of a Panton-Valentine Leucocidin-Positive, Methicillin-Resistant Staphylococcus aureus Strain between Humans and a Dog. J. Clin. Microbiol. 43: 6209-6211 [Abstract] [Full Text]  
  • Roesch, A., Linde, H.-J., Landthaler, M., Vogt, T. (2005). Elimination of a Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection in a Nurse With Atopic Dermatitis. Arch Dermatol 141: 1520-1522 [Full Text]  
  • McAleese, F., Murphy, E., Babinchak, T., Singh, G., Said-Salim, B., Kreiswirth, B., Dunman, P., O'Connell, J., Projan, S. J., Bradford, P. A. (2005). Use of Ribotyping To Retrospectively Identify Methicillin-Resistant Staphylococcus aureus Isolates from Phase 3 Clinical Trials for Tigecycline That Are Genotypically Related to Community-Associated Isolates. Antimicrob. Agents Chemother. 49: 4521-4529 [Abstract] [Full Text]  
  • Issartel, B., Tristan, A., Lechevallier, S., Bruyere, F., Lina, G., Garin, B., Lacassin, F., Bes, M., Vandenesch, F., Etienne, J. (2005). Frequent Carriage of Panton-Valentine Leucocidin Genes by Staphylococcus aureus Isolates from Surgically Drained Abscesses. J. Clin. Microbiol. 43: 3203-3207 [Abstract] [Full Text]  
  • Takizawa, Y., Taneike, I., Nakagawa, S., Oishi, T., Nitahara, Y., Iwakura, N., Ozaki, K., Takano, M., Nakayama, T., Yamamoto, T. (2005). A Panton-Valentine Leucocidin (PVL)-Positive Community-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Strain, Another Such Strain Carrying a Multiple-Drug Resistance Plasmid, and Other More-Typical PVL-Negative MRSA Strains Found in Japan. J. Clin. Microbiol. 43: 3356-3363 [Abstract] [Full Text]  
  • Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., Spellberg, B. (2005). Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus in Los Angeles. NEJM 352: 1445-1453 [Abstract] [Full Text]  
  • Cassat, J. E., Dunman, P. M., McAleese, F., Murphy, E., Projan, S. J., Smeltzer, M. S. (2005). Comparative Genomics of Staphylococcus aureus Musculoskeletal Isolates. J. Bacteriol. 187: 576-592 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diep, B. A.
Right arrow Articles by Perdreau-Remington, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diep, B. A.
Right arrow Articles by Perdreau-Remington, F.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»